MOMIPP,一种巨胞饮作用的诱导剂,是一种PIKfyve抑制剂。MOMIPP 可穿过血脑屏障 (BBB)。
生物活性 | MOMIPP, a macropinocytosis inducer, is aPIKfyveinhibitor. MOMIPP penetrates the blood-brain barrier (BBB)[1][2]. |
体外研究 (In Vitro) | MOMIPP can induce intense macropinocytosis, leading to methuosis in cultured glioblastoma cells at low micromolar concentrations[1]. In U373 and Hs683 cell lines, 3 μM for MOMIPP induces cell vacuolization[1]. MOMIPP (10 μM) causes early disruptions of glucose uptake and glycolytic metabolism. MOMIPP selectively activates the JNK1/2 stress kinase pathway, resulting in phosphorylation of c-Jun, Bcl-2 and Bcl-xL[2].
Western Blot Analysis[2] Cell Line: | U251 cells | Concentration: | 10 μM | Incubation Time: | 4 h or 24 h | Result: | Activated the JNK stress kinase pathway. |
|
体内研究 (In Vivo) | MOMIPP (80 mg/kg; i.p.; once daily; for 15 consecutive days) shows moderately effective in suppressing progression of intracerebral glioblastoma xenografts[2].
Animal Model: | Athymic CrTac:NCR-Foxn1mice (female, 7-8 weeks)[2] | Dosage: | 80 mg/kg | Administration: | i.p.; once daily; for 15 consecutive days | Result: | Suppressed progression of intracerebral glioblastoma xenografts. |
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Powder | -20°C | 3 years | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
溶解性数据 | In Vitro: DMSO : 31.25 mg/mL(106.90 mM;ultrasonic and warming and heat to 60℃) 配制储备液 1 mM | 3.4208 mL | 17.1040 mL | 34.2079 mL | 5 mM | 0.6842 mL | 3.4208 mL | 6.8416 mL | 10 mM | 0.3421 mL | 1.7104 mL | 3.4208 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 |